As shown in Fig. 5A, the increased phosphorylation of Smad2/3 and p38 following tumor exosomes treatment was reversed by TGF-β R1 inhibitor, SD208, in a dose-dependent manner. The gene discussed is SMAD2; the disease is neoplasm.